Mode
Text Size
Log in / Sign up

Dietary restriction may influence neuroinflammation in neurodegenerative and neurological disorders.

Dietary restriction may influence neuroinflammation in neurodegenerative and neurological disorders.
Photo by BUDDHI Kumar SHRESTHA / Unsplash
Key Takeaway
Consider dietary restriction only as a potential future adjunctive strategy pending further high-quality research.

This narrative review evaluates the potential role of dietary restriction (DR) in the context of neurodegenerative and neurological disorders. DR is defined as chronic or intermittent reduction of calories or nutrients without inducing malnutrition. The primary focus of the discussion is on neuroinflammation and related biological mechanisms.

The review does not report specific study designs, sample sizes, or quantitative data regarding primary or secondary outcomes. Consequently, no exact numbers or statistical results are available to support definitive clinical conclusions. Safety data, including adverse events, serious adverse events, discontinuations, and overall tolerability, were not reported in the source material.

Key limitations include the lack of reported study phase, setting, and specific comparators. The review does not establish causality between DR and changes in neuroinflammation. Funding sources and potential conflicts of interest were not reported. Due to the absence of randomized controlled trial data or specific patient cohorts, the certainty of the findings is low.

The practice relevance suggests that DR holds potential as an adjunctive strategy for future therapeutic investigations in this field. Clinicians should interpret these findings cautiously, recognizing that current evidence is insufficient to recommend DR as a standard intervention. Further high-quality research is needed to determine efficacy and safety profiles.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Dietary restriction (DR) involving chronic or intermittent calorie/nutrient reduction without malnutrition, delays neurological disease progression. Decades of research across in vitro models, animal studies, and clinical trials provide preclinical evidence for a potential role of DR in modulating multiple mechanisms underlying CNS disorders. Interactions between caloric intake, meal frequency, diet composition, and the gut microbiome regulate specific metabolic pathways governing cellular, tissue, and organ homeostasis as well as inflammatory processes during neurodegenerative and neurological diseases. In this review, we synthesize evidence on the role of DR in modulating neuroinflammation and related mechanisms within a selected set of neurodegenerative and neurological disorders, aims to provide a consolidated evidence base and perspective on the potential of DR as an adjunctive strategy for the future therapeutic investigations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.